Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bram, De Wel"'
Autor:
Bram De Wel, Lotte Huysmans, Ronald Peeters, Stefan Ghysels, Kris Byloos, Guido Putzeys, Frederik Maes, Patrick Dupont, Kristl G. Claeys
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 5, Pp 1761-1771 (2024)
Abstract Background We investigated the potential of magnetic resonance elastography (MRE) stiffness measurements in skeletal muscles as an outcome measure, by determining its test–retest reliability, as well as its sensitivity to change in a longi
Externí odkaz:
https://doaj.org/article/d3395bb9e44948d2a3f94001e19c3c5f
Autor:
Bram De Wel, Lotte Huysmans, Christophe E. Depuydt, Veerle Goosens, Ronald Peeters, Filipa P. Santos, Dietmar R. Thal, Patrick Dupont, Frederik Maes, Kristl G. Claeys
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 3, Pp 1468-1481 (2023)
Abstract Background Despite the widespread use of proton density fat fraction (PDFF) measurements with magnetic resonance imaging (MRI) to track disease progression in muscle disorders, it is still unclear how these findings relate to histopathologic
Externí odkaz:
https://doaj.org/article/f286867d6bd14e3eb8e4d4ab26587d3a
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 9, Iss 8, Pp 1241-1251 (2022)
Abstract Objective To investigate biomarkers of disease progression in cerebrospinal fluid (CSF) and serum in adult patients with spinal muscular atrophy (SMA). Furthermore, we assess the clinical response to nusinersen treatment in adults with SMA o
Externí odkaz:
https://doaj.org/article/8f23d34f4aab4b0b865e8f07b3acea96
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Muscular dystrophies (MD) are a class of rare genetic diseases resulting in progressive muscle weakness affecting specific muscle groups, depending on the type of disease. Disease progression is characterized by the gradual replacement of muscle tiss
Externí odkaz:
https://doaj.org/article/b93175c2bd70477284abbb95c46e7d14
Autor:
Bram De Wel, Kristl G. Claeys
Publikováno v:
Neurology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d7015c9f634c9cbce5bd67533131995
https://europepmc.org/articles/PMC9969921/
https://europepmc.org/articles/PMC9969921/
Autor:
Atka Sobota, Elke Van Camp, Griet Van Kerschaver, Kathleen Claes, Ellen Geukens, Marlène Jagut, Veerle Goosens, Kristl G. Claeys, Bram De Wel
Publikováno v:
Journal of Neurology. 268:923-935
Nusinersen recently became available as the first treatment for Spinal Muscular Atrophy (SMA) and data on its effectiveness and safety in adult SMA patients are still scarce. We evaluated the effectiveness and safety of nusinersen treatment during 14
Autor:
Bram De Wel, Lotte Huysmans, Ronald Peeters, Veerle Goosens, Stefan Ghysels, Kris Byloos, Guido Putzeys, Ann D'Hondt, Jan L. De Bleecker, Patrick Dupont, Frederik Maes, Kristl G. Claeys
Publikováno v:
Neurology. 99(6)
Background and ObjectivesLimb-girdle muscular dystrophy autosomal recessive type 12 (LGMDR12) is a rare hereditary muscular dystrophy for which outcome measures are currently lacking. We evaluated quantitative MRI and clinical outcome measures to tra
Autor:
Kristl G. Claeys, Bram De Wel
Publikováno v:
Current opinion in neurology. 34(5)
To provide an update on recent developments regarding acquired, antibody-mediated, neuromuscular hyperexcitability syndromes, including Isaac's and Morvan's syndromes, cramp-fasciculation syndrome and rippling muscle disease, and their genetic differ
Autor:
Bertien Buyse, Sofie Willaert, Dries Testelmans, Anne-Catherine Aubé-Nathier, Bram De Wel, Aleksandra Nadaj-Pakleza, Kristl G. Claeys
Publikováno v:
Neuromuscular disorders : NMD. 31(3)
Becker muscular dystrophy (BMD) is a rare hereditary neuromuscular disease, caused by a genetic defect in the Duchenne Muscular Dystrophy (DMD) gene. We studied the natural history of respiratory function and its affecting factors in 23 adult BMD pat
Autor:
Bram, De Wel, Veerle, Goosens, Atka, Sobota, Elke, Van Camp, Ellen, Geukens, Griet, Van Kerschaver, Marlène, Jagut, Kathleen, Claes, Kristl G, Claeys
Publikováno v:
Journal of neurology. 268(3)
Nusinersen recently became available as the first treatment for Spinal Muscular Atrophy (SMA) and data on its effectiveness and safety in adult SMA patients are still scarce.We evaluated the effectiveness and safety of nusinersen treatment during 14